Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response of Platelet Count to Helicobacter pylori Screening and PPI-based Triple Therapy in Immune Thrombocytopenic Purpura
TCTR20220801005Phase 3Unknown
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clarithromycin, amoxicillin in immune thrombocytopenia (ITP), Helicobacter pylori infection, sponsored by Faculty of Medicine, Chiang Mai University. Status: unknown.
02
Drugs
clarithromycinamoxicillin
03
Conditions
immune thrombocytopenia (ITP)Helicobacter pylori infection
Beyond the preview
Go deeper on TCTR20220801005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220801005.